Realistic Mass Casualty Medical Simulation Capabilities RFI
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Advanced Research Projects Agency (DARPA), specifically its Biological Technologies Office (BTO), has issued a Request for Information (RFI) for Realistic Mass Casualty Medical Simulation Capabilities. This RFI seeks input from industry, government, military, and civilian entities on their ability to plan, resource, execute, and assess high-fidelity, large-scale mass casualty (MASCAL) medical simulation events. DARPA is interested in capabilities involving greater than 50, 100, or 200 simulated patients within a single event lasting less than 72 hours. This is for information gathering and planning purposes only and does not constitute a solicitation. Responses are due May 31, 2026.
Scope of Information Requested
DARPA is requesting a maximum 3-page white paper detailing organizational experience and approach to creating high-fidelity MASCAL medical simulations. Key areas of interest include:
- Organizational Capabilities and Past Performance: Experience with MASCAL simulations (at least 25 casualties), noting events exceeding 50, 100, or 200 simulated patients within 72 hours, and any experience with DoD, DARPA, or other U.S. Government agencies.
- MASCAL Simulation Execution Capabilities: Details on realism elements such as moulage techniques, injury catalog, use of live actors, physiology-enabled medical manikins (make, model, fidelity, quantity), Class VIII consumables, and Augmented/Virtual/Mixed Reality (AR/VR/MR) solutions. Visual documentation is encouraged.
- Data Collection and Assessment: Experience and approach for collecting performance data (e.g., time-to-tourniquet, triage accuracy), data collection methods (observer-controllers, sensors, AAR), analytic methods, and any performance benchmarks or validated assessment instruments.
- Cost and Resourcing: A rough estimate of overall event cost and average cost per casualty.
Submission Details
- Format: PDF, maximum 3 pages (including graphics), 12-point font, 1-inch margins.
- Content: Non-proprietary information is encouraged. Proprietary information must be clearly labeled. Classified information should not be included.
- Submission Deadline: May 31, 2026, 4:00 PM ET.
- Submission Email: MASCAL_RFI@darpa.mil
Contract & Timeline
- Type: Special Notice / Request for Information (RFI)
- Set-Aside: None specified.
- Response Due: May 31, 2026, 4:00 PM ET.
- Published: May 15, 2026.
Additional Notes
This RFI is solely for information gathering and planning purposes and does not constitute a solicitation for proposals or an intent to fund. Responses are voluntary, and DARPA will not reimburse for costs incurred. DARPA is under no obligation to acknowledge receipt or provide feedback.